Correlation Between Lumos Pharma and Purple Biotech
Can any of the company-specific risk be diversified away by investing in both Lumos Pharma and Purple Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lumos Pharma and Purple Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lumos Pharma and Purple Biotech, you can compare the effects of market volatilities on Lumos Pharma and Purple Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lumos Pharma with a short position of Purple Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lumos Pharma and Purple Biotech.
Diversification Opportunities for Lumos Pharma and Purple Biotech
0.29 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Lumos and Purple is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Lumos Pharma and Purple Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Purple Biotech and Lumos Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lumos Pharma are associated (or correlated) with Purple Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Purple Biotech has no effect on the direction of Lumos Pharma i.e., Lumos Pharma and Purple Biotech go up and down completely randomly.
Pair Corralation between Lumos Pharma and Purple Biotech
If you would invest 434.00 in Lumos Pharma on November 4, 2024 and sell it today you would earn a total of 0.00 from holding Lumos Pharma or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 5.0% |
| Values | Daily Returns |
Lumos Pharma vs. Purple Biotech
Performance |
| Timeline |
| Lumos Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Purple Biotech |
Lumos Pharma and Purple Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lumos Pharma and Purple Biotech
The main advantage of trading using opposite Lumos Pharma and Purple Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lumos Pharma position performs unexpectedly, Purple Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Purple Biotech will offset losses from the drop in Purple Biotech's long position.| Lumos Pharma vs. Shattuck Labs | Lumos Pharma vs. Champions Oncology | Lumos Pharma vs. Century Therapeutics | Lumos Pharma vs. Silo Pharma |
| Purple Biotech vs. Pluri Inc | Purple Biotech vs. BioLineRx | Purple Biotech vs. Enlivex Therapeutics | Purple Biotech vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |